Get the latest Science News and Discoveries

Insilico Medicine reports positive Phase IIa results for ISM001-055, a novel first-in-class drug treatment for idiopathic pulmonary fibrosis (IPF) designed using generative AI - EurekAlert


Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of EurekAlert

EurekAlert

Photo of Insilico Medicine

Insilico Medicine

Related news:

News photo

Scientists from 33 European countries join fo - EurekAlert

News photo

NASA’s Hubble finds more black holes than expected in the early universe - EurekAlert

News photo

Central America could play troubling new role in cocaine trade - EurekAlert